by Peter Ciszewski | Jul 31, 2020
Jennifer Elliott, PhD, Global Project Leader at Takeda Oncology, discusses the results of the phase 2 P2001 study presented at ASCO 2020. This clinical trial’s primary goal was to determine whether the combination of pevonedistat and azacitidine improves...
by Peter Ciszewski | Jul 30, 2020
Ronald Hoffman, MD, Director of the Myeloproliferative Diseases Program at The Icahn School of Medicine at Mount Sinai, describes the typical treatment options for polycythemia vera. Polycythemia vera, as outlined by the NIH, is a rare blood disorder...
by Peter Ciszewski | Jul 29, 2020
Jonathan Sorof, MD, Senior Vice President, Head of Medical Affairs at Global Blood Therapeutics (GBT), talks about the newer treatment options that are now available for persons with sickle cell disease. Sickle cell disease is a rare hematologic condition and early...
by Peter Ciszewski | Jul 28, 2020
Ozlem Goker-Alpan, MD provides a summary of research presented at WORLDSymposium 2020 focused on the cardiovascular problems associated with Fabry disease. This video resource is part of the CME activity Fabry Disease Highlights from WORLDSymposium 2020, which...
by Peter Ciszewski | Jul 27, 2020
Diego Cadavid, MD of Fulcrum Therapeutics provides an update on the Phase 2 Clinical Trial testing the safety and efficacy of losmapimod to treat facioscapulohumeral muscular dystrophy (FSHD). FSHD is a rare, progressive musculoskeletal disease in which persons...
